FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: PeakClear all
TRIKAFTA (COPACKAGED)
elexacaftor, tezacaftor, and ivacaftor
Peak
Vertex Pharmaceuticals
ORAL · TABLET
cystic fibrosis (CF) in patients aged 2 yearsolder+1
2019
NDA
0/100
TRINTELLIX
vortioxetine
Peak
Takeda
ORAL · TABLET
major depressive disorder (MDD) in adults (
2013
NDA
0/100
TRUDHESA
dihydroergotamine mesylate
Peak
NASAL · SPRAY, METERED
2021
NDA
0/100
TRULANCE
plecanatide
Peak
Salix Pharmaceuticals
ORAL · TABLET
2017
PeptideNDA
0/100
TRUSELTIQ
infigratinib phosphate
Peak
Helsinn
ORAL · CAPSULE
2021
NDA
0/100
TUKYSA
tucatinib
Peak
Pfizer
ORAL · TABLET
2020
SMNDA
0/100
TURALIO
pexidartinib hydrochloride
Peak
Daiichi Sankyo
ORAL · CAPSULE
functional limitationsnot amenable to improvement with surgery
2019
NDA
0/100
TUXARIN ER
codeine phosphate and chlorpheniramine maleate
Peak
ORAL · TABLET, EXTENDED RELEASE
2015
NDA
0/100
TWYNEO
tretinoin and benzoyl peroxide
Peak
TOPICAL · CREAM
2021
NDA
0/100
TYBOST
cobicistat
Peak
Gilead Sciences
ORAL · TABLET
2014
SMNDA
0/100
TYMLOS
abaloparatide
Peak
Radius Health
SUBCUTANEOUS · SOLUTION
2017
PeptideNDA
0/100
TYRVAYA
varenicline
Peak
NASAL · SPRAY
2021
NDA
0/100
TYVASO
treprostinil
Peak
United Therapeutics
INHALATION · SOLUTION
2009
NDA
0/100
TYVASO DPI
treprostinil
Peak
United Therapeutics
INHALATION · POWDER
2022
NDA
0/100
TYZAVAN
vancomycin
Peak
Hikma
INTRAVENOUS · SOLUTION
2019
NDA
0/100
UBRELVY
ubrogepant
Peak
AbbVie
ORAL · TABLET
2019
NDA
0/100
UCERIS
budesonide
Peak
Salix Pharmaceuticals
ORAL · TABLET, EXTENDED RELEASE
2013
NDA
0/100
UKONIQ
umbralisib tosylate
Peak
TG Therapeutics
ORAL · TABLET
2021
NDA
0/100
ULORIC
febuxostat
Peak
Takeda
ORAL · TABLET
2009
SMNDA
0/100
ULTRAVATE
halobetasol propionate
Peak
Lacer
TOPICAL · LOTION
2015
NDA
0/100
UPNEEQ
oxymetazoline hydrochloride ophthalmic
Peak
OPHTHALMIC · SOLUTION/DROPS
2020
NDA
0/100
UPTRAVI
selexipag
Peak
Johnson & Johnson
ORAL · TABLET
2015
NDA
0/100
VABOMERE
meropenem-vaborbactam
Peak
INTRAVENOUS · POWDER
2017
NDA
0/100
VALTOCO
diazepam
Peak
Neurelis
NASAL · SPRAY
2020
NDA
0/100